Cargando…

Detection of bacteria via multiplex PCR in respiratory samples of critically ill COVID-19 patients with suspected HAP/VAP in the ICU

BACKGROUND: Critically ill Coronavirus disease 2019 (COVID-19) patients have high rates of bacterial superinfection. Multiplex polymerase chain reaction panels may be able to provide useful information about the incidence and spectrum of bacteria causing superinfections. METHODS: In this retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karolyi, Mario, Pawelka, Erich, Hind, Julian, Baumgartner, Sebastian, Friese, Emanuela, Hoepler, Wolfgang, Neuhold, Stephanie, Omid, Sara, Seitz, Tamara, Traugott, Marianna T., Wenisch, Christoph, Zoufaly, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656439/ https://www.ncbi.nlm.nih.gov/pubmed/34882256 http://dx.doi.org/10.1007/s00508-021-01990-0

Ejemplares similares

Clinical and Angiographic Features in Three COVID-19 Patients with Takotsubo Cardiomyopathy. Case Report
por: Hoepler, Wolfgang, et al.
Publicado: (2021)

COVID-19-associated myoclonus in a series of five critically ill patients
por: Grieb, Alexander, et al.
Publicado: (2021)

Rapid Detection of Bacterial and Fungal Pathogens Using the T2MR versus Blood Culture in Patients with Severe COVID-19
por: Seitz, Tamara, et al.
Publicado: (2022)

Diagnostik und Therapie von COVID-19 auf der Intensivstation
por: Hoepler, Wolfgang, et al.
Publicado: (2022)

Diagnosis of COVID-19 using multiple antibody assays in two cases with negative PCR results from nasopharyngeal swabs
por: Traugott, Marianna Theresia, et al.
Publicado: (2020)

Late onset pulmonary embolism in young male otherwise healthy COVID-19 patients
por: Karolyi, M., et al.
Publicado: (2020)

COVID-19 is not “just another flu”: a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, Austria
por: Pawelka, Erich, et al.
Publicado: (2021)

Correction to: COVID-19 is not “just another flu”: a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, Austria
por: Pawelka, Erich, et al.
Publicado: (2021)

Successful management of the first reported case in Austria of COVID-19 with ARDS
por: Seitz, T., et al.
Publicado: (2020)

High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19
por: Karolyi, Mario, et al.
Publicado: (2021)

Tocilizumab vs. baricitinib in hospitalized severe COVID-19 patients: results from a real-world cohort
por: Karolyi, Mario, et al.
Publicado: (2022)

Comparison of clinical characteristics among patients infected with alpha vs. delta SARS-CoV-2 variants
por: Rumpf, Benedikt, et al.
Publicado: (2022)

Hydroxychloroquine versus lopinavir/ritonavir in severe COVID-19 patients: Results from a real-life patient cohort
por: Karolyi, Mario, et al.
Publicado: (2020)

Evaluation of Five Commercial SARS-CoV-2 Antigen Tests in a Clinical Setting
por: Seitz, Tamara, et al.
Publicado: (2022)

Early administration of remdesivir may reduce mortality in hospitalized COVID-19 patients: A propensity score matched analysis
por: Karolyi, Mario, et al.
Publicado: (2022)

Successful treatment of intubation-induced severe neurogenic post-extubation dysphagia using pharyngeal electrical stimulation in a COVID-19 survivor: a case report
por: Traugott, Marianna, et al.
Publicado: (2021)

The Role of Bacterial and Fungal Superinfection in Critical COVID-19
por: Seitz, Tamara, et al.
Publicado: (2022)

Human recombinant soluble ACE2 in severe COVID-19
por: Zoufaly, Alexander, et al.
Publicado: (2020)

Camostat Mesylate Versus Lopinavir/Ritonavir in Hospitalized Patients With COVID-19—Results From a Randomized, Controlled, Open Label, Platform Trial (ACOVACT)
por: Karolyi, M., et al.
Publicado: (2022)

Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays
por: Semmler, Georg, et al.
Publicado: (2021)

Is there a clinical difference between influenza A and B virus infections in hospitalized patients?: Results after routine polymerase chain reaction point-of-care testing in the emergency room from 2017/2018
por: Karolyi, Mario, et al.
Publicado: (2019)

Correction: A case of fulminant respiratory diphtheria in a 24-year-old Afghan refugee in Austria in May 2022: a case report
por: Traugott, M. T., et al.
Publicado: (2023)

A case of fulminant respiratory diphtheria in a 24-year-old Afghan refugee in Austria in May 2022: a case report
por: Traugott, M. T., et al.
Publicado: (2022)

Application of VAP bundles resulting in low incidence of VAP in ICU
por: Khan, FM, et al.
Publicado: (2011)

Age Related Differences in Monocyte Subsets and Cytokine Pattern during Acute COVID-19—A Prospective Observational Longitudinal Study
por: Pirabe, Anita, et al.
Publicado: (2021)

Immunoglobulin G production in COVID-19 - associations with age, outcome, viral persistence, inflammation and pro-thrombotic markers
por: Pirabe, Anita, et al.
Publicado: (2023)

115. Evaluation of the Clinical Impact of the T2MR for the Diagnosis of Bloodstream Infections
por: Seitz, Tamara, et al.
Publicado: (2019)

Empiric Treatment in HAP/VAP: “Don’t You Want to Take a Leap of Faith?”
por: Chaïbi, Khalil, et al.
Publicado: (2022)

Platelet Phenotype Analysis of COVID-19 Patients Reveals Progressive Changes in the Activation of Integrin αIIbβ3, F13A1, the SARS-CoV-2 Target EIF4A1 and Annexin A5
por: Ercan, Huriye, et al.
Publicado: (2021)

Monkeypox associated acute arthritis
por: Fonti, Mirella, et al.
Publicado: (2022)

Muscle involvement in SARS‐CoV‐2 infection
por: Pitscheider, Lea, et al.
Publicado: (2020)

Metagenomics for the microbiological diagnosis of hospital-acquired pneumonia and ventilator-associated pneumonia (HAP/VAP) in intensive care unit (ICU): a proof-of-concept study
por: Heitz, Morgane, et al.
Publicado: (2023)

Evidence supporting recommendations from international guidelines on treatment, diagnosis, and prevention of HAP and VAP in adults
por: Campogiani, Laura, et al.
Publicado: (2019)

How to approach and treat VAP in ICU patients
por: Borgatta, Bárbara, et al.
Publicado: (2014)

Molecular diagnosis of autochthonous human anaplasmosis in Austria – an infectious diseases case report
por: Hoepler, Wolfgang, et al.
Publicado: (2020)

The natural killer cell‐associated rs9916629‐C allele is a novel genetic risk factor for fatal COVID‐19
por: Vietzen, Hannes, et al.
Publicado: (2022)

Periodontitis leads to VAP in ICU patients: A dental note
por: Saini, Rajiv, et al.
Publicado: (2010)

How to treat VAP due to MDR pathogens in ICU patients
por: Garnacho-Montero, José, et al.
Publicado: (2014)

Randomized controlled study to evaluate the safety and clinical impact of percutaneous auricular vagus nerve stimulation in patients with severe COVID-19
por: Seitz, Tamara, et al.
Publicado: (2023)

Platelets and Antiplatelet Medication in COVID-19-Related Thrombotic Complications
por: Schrottmaier, Waltraud C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8jgpn6qeukvtu2trba2g8et5k7